GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (FRA:0KB2) » Definitions » Shiller PE Ratio

Humanigen (FRA:0KB2) Shiller PE Ratio : (As of May. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Humanigen Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Humanigen Shiller PE Ratio Historical Data

The historical data trend for Humanigen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanigen Shiller PE Ratio Chart

Humanigen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Humanigen Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Humanigen's Shiller PE Ratio

For the Biotechnology subindustry, Humanigen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humanigen's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Humanigen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Humanigen's Shiller PE Ratio falls into.



Humanigen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Humanigen's E10 for the quarter that ended in Mar. 2023 is calculated as:

For example, Humanigen's adjusted earnings per share data for the three months ended in Mar. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.037/127.3478*127.3478
=-0.037

Current CPI (Mar. 2023) = 127.3478.

Humanigen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201306 -14.857 98.518 -19.205
201309 -14.062 98.790 -18.127
201312 -7.300 98.326 -9.455
201403 -9.254 99.695 -11.821
201406 -8.758 100.560 -11.091
201409 -7.605 100.428 -9.644
201412 -9.570 99.070 -12.302
201503 -10.765 99.621 -13.761
201506 -6.504 100.684 -8.226
201509 -7.128 100.392 -9.042
201512 -14.550 99.792 -18.568
201603 -5.478 100.470 -6.943
201606 -11.704 101.688 -14.657
201609 -1.336 101.861 -1.670
201612 -1.601 101.863 -2.002
201703 -1.730 102.862 -2.142
201706 -1.825 103.349 -2.249
201709 -2.014 104.136 -2.463
201712 -0.887 104.011 -1.086
201803 -0.405 105.290 -0.490
201806 -0.086 106.317 -0.103
201809 -0.086 106.507 -0.103
201812 -0.088 105.998 -0.106
201903 -0.089 107.251 -0.106
201906 -0.133 108.070 -0.157
201909 -0.100 108.329 -0.118
201912 -0.081 108.420 -0.095
202003 -0.100 108.902 -0.117
202006 -0.702 108.767 -0.822
202009 -0.603 109.815 -0.699
202012 -0.518 109.897 -0.600
202103 -1.050 111.754 -1.197
202106 -0.996 114.631 -1.106
202109 -0.952 115.734 -1.048
202112 -0.425 117.630 -0.460
202203 -0.291 121.301 -0.306
202206 -0.407 125.017 -0.415
202209 -0.232 125.227 -0.236
202212 0.151 125.222 0.154
202303 -0.037 127.348 -0.037

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Humanigen  (FRA:0KB2) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Humanigen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Humanigen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Humanigen (FRA:0KB2) Business Description

Traded in Other Exchanges
Address
830 Morris Turnpike, 4th Floor, Short Hills, NJ, USA, 07078
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.

Humanigen (FRA:0KB2) Headlines

No Headlines